Review
doi: 10.1016/j.drudis.2009.12.006.
Epub 2010 Jan 4.
Circulating tumour-derived predictive biomarkers in oncology
Affiliations
- PMID: 20045486
- DOI: 10.1016/j.drudis.2009.12.006
Item in Clipboard
Review
Circulating tumour-derived predictive biomarkers in oncology
Drug Discov Today.
2010 Feb.
Abstract
Molecular characterization of tumour material will become increasingly important in selecting patients for clinical trials and offering appropriate treatment for patients in clinical practice. Recent advances in the field have indicated that the molecular characteristics of a tumour can be determined from circulating tumour cells and circulating tumour DNA; thus, a simple blood sample could provide these data in a simple, convenient and efficient manner. This article discusses progress towards guiding treatment decisions through measuring tumour-derived factors in the circulation.
Copyright (c) 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Reproducibility of a semiquantitative measurement of circulating DNA in plasma from neoplastic patients.J Clin Oncol. 2005 May 1;23(13):3163-4; author reply 3164-5. doi: 10.1200/JCO.2005.05.430. J Clin Oncol. 2005. PMID: 15860889 No abstract available.
-
Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities.Cancer Treat Rev. 2014 Jun;40(5):648-55. doi: 10.1016/j.ctrv.2013.10.003. Epub 2013 Oct 23. Cancer Treat Rev. 2014. PMID: 24184333 Review.
-
Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?Lung Cancer. 2005 Jul;49(1):1-12. doi: 10.1016/j.lungcan.2004.12.008. Lung Cancer. 2005. PMID: 15949585 Review.
-
Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.Lung Cancer. 2009 Apr;64(1):92-7. doi: 10.1016/j.lungcan.2008.07.012. Epub 2008 Sep 19. Lung Cancer. 2009. PMID: 18804892
-
Assessing cancer with a blood draw.J Natl Cancer Inst. 2012 Dec 5;104(23):1774-5. doi: 10.1093/jnci/djs495. J Natl Cancer Inst. 2012. PMID: 23213181 No abstract available.
Cited by
-
Multiparametric analysis of cell-free DNA in melanoma patients.PLoS One. 2012;7(11):e49843. doi: 10.1371/journal.pone.0049843. Epub 2012 Nov 27. PLoS One. 2012. PMID: 23209607 Free PMC article.
-
Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours.Hugo J. 2010 Dec;4(1-4):11-21. doi: 10.1007/s11568-011-9149-2. Epub 2011 Jan 30. Hugo J. 2010. PMID: 22132062 Free PMC article.
-
KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation.Oncol Lett. 2021 Jan;21(1):15. doi: 10.3892/ol.2020.12276. Epub 2020 Nov 6. Oncol Lett. 2021. PMID: 33240421 Free PMC article.
-
Plasma tumor DNA: on your markers, get set, go!Ann Transl Med. 2014 Jan;2(1):2. doi: 10.3978/j.issn.2305-5839.2013.06.07. Ann Transl Med. 2014. PMID: 25332978 Free PMC article.
-
Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring.Int J Mol Sci. 2021 Sep 8;22(18):9714. doi: 10.3390/ijms22189714. Int J Mol Sci. 2021. PMID: 34575876 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
